Gastroparesis Market SWOT and PEST Analysis 2021-2031

Gastroparesis Market Size and Forecast (2021–2031), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Type (Idiopathic, Diabetic, Post-Surgical, and Others), Drug Class (Prokinetic Agents, Botulinum Toxin Injection, and Antiemetic Agents), Distribution Channel (Retail Pharmacies, Hospital Pharmacies, and Others), and Geography

  • Report Code : TIPRE00008992
  • Category : Pharmaceuticals
  • Status : Data Released
  • No. of Pages : 150
Buy Now

The Gastroparesis Market size is projected to reach US$ 7.39 billion by 2031 from US$ 5.03 billion in 2023. The market is expected to register a CAGR of 4.9% in 2023–2031. Technological advancement and increasing research on gastric electrical stimulation are likely to remain key Gastroparesis Market trends.

Gastroparesis Market Analysis

Gastroparesis is a functional disorder of the stomach affecting nerves and muscles which leads to slower gastric movements. Major factors driving the gastroparesis market growth includes the increasing prevalence of idiopathic gastroparesis followed by the rising prevalence of diabetes mellitus which leads to the gastroparesis. Moreover, the increasing geriatric population contributes to the rising prevalence of gastroparesis owing to inadequate appetite regulation, poor oral medication absorption, and postprandial glycemia. Aging leads to the diminished bodily functions such as physiologic functions and slowing of gastric emptying which influences the motor and sensory functions among the geriatric population.

Gastroparesis Market Overview

The gastroparesis market has seen tremendous growth in last few years owing to the increasing awareness of conditions and improved diagnostic techniques and the development of new options. The market players are actively involved in the research and development of effective treatment options which can help in the effective management of the condition. Moreover, effective technologies such as gastric electrical stimulation are used to improve the gastric mobility among patients with severe gastroparesis. Moreover, increasing research will lead to the development of novel therapies and personalized treatment approaches for the gastroparesis.

Customize Research To Suit Your Requirement

We can optimize and tailor the analysis and scope which is unmet through our standard offerings. This flexibility will help you gain the exact information needed for your business planning and decision making.

Gastroparesis Market: Strategic Insights

Gastroparesis Market

  • CAGR (2023 - 2031)
  • Market Size 2023
    US$ 5.03 billion
  • Market Size 2031
    US$ 7.39 billion

Market Dynamics

  • Increasing prevelance of Diabetes Mellitus
  • Technological Advancements and incresaing research on gastric stimulation
  • Surging Clinical Trials

Key Players

  • Bausch Health Companies Inc.(Salix Pharmaceuticals, Ltd.)
  • Johnson And Johnson Services, Inc.
  • Allergan Plc
  • Pfizer Inc.
  • ANI Pharmaceuticals, Inc.
  • Ipca Laboratories Ltd.
  • Cinrx Pharma, LLC (Cindome Pharma)

Regional Overview

  • North America
  • Europe
  • Asia-Pacific
  • South and Central America
  • Middle East and Africa

Market Segmentation

  • Idiopathic
  • Diabetic
  • Post-Surgical
  • Others
Drug Class Type
  • Prokinetic Agents
  • Antiemetic Agents
  • Botulinum Toxin Injection
Distribution Channel
  • Hospital Pharmacies
  • Retail Pharmacies
  • Others
  • Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.

Gastroparesis Market Drivers and Opportunities

Rising Diabetes Mellitus Prevalence to Favor Market

Diabetes is one of the prominent known causes of gastroparesis. The condition is characterized by damaged nerves, especially involving vagus nerves and stomach wall cells. The damage to vagus nerves affects muscle motility of the stomach and small intestine. According to a study published by Johns Hopkins University, ~30–50% of the diabetic population suffers from delayed gastric emptying. The escalating incidence of diabetes mellitus due to obesity, a sedentary lifestyle, and unhealthy eating habits is propelling the prevalence of gastroparesis.

Increasing Clinical Trials are likely to create Market Opportunities

The increasing prevalence of gastroparesis has created a demand for effective and advanced treatment with better outcomes. This has tremendously increased the number of clinical trials globally which is expected to provide better treatment options to the large patient population by testing the safety and efficacy of the newly developed drugs. Some of the ongoing clinical trails for gastroparesis drugs are mentioned below:

 Drug Name






RM -131
















Gastroparesis Market Report Segmentation Analysis

Key segments that contributed to the derivation of the Gastroparesis Market analysis are type, drug class, and distribution channel.

  • Based on type, the Gastroparesis Market is segmented into idiopathic, diabetic, post-surgical, others. The idiopathic segment held a larger market share in 2023.
  • By drug class type, the market is segmented into prokinetic agents, botulinum toxin injection, and antiemetic agents. The prokinetic agents segment held the largest share of the market in 2023.
  • In terms of distribution channel, the market is categorized into retail pharmacies, hospital pharmacies, and others. The hospital pharmacies segment dominated the market in 2023.

Gastroparesis Market Share Analysis by Geography

The geographic scope of the Gastroparesis Market report is mainly divided into five regions: North America, Asia Pacific, Europe, Middle East & Africa, and South & Central America.

North America has dominated the Gastroparesis Market owing to the rising prevalence of gastroparesis. In addition, the aging population and growing prevalence of diabetes are also projected to offer lucrative opportunities for the growth of the North America gastroparesis market during the forecast period. In addition, extensive research in pharmaceutical and biotechnology companies is further expected to stimulate the growth of the gastroparesis market in North America. Asia Pacific is anticipated to grow with the highest CAGR in the coming years.

Gastroparesis Market Report Scope

Report Attribute Details
Market size in 2023 US$ 5.03 billion
Market Size by 2031 US$ 7.39 billion
Global CAGR (2023 - 2031) 4.9%
Historical Data 2021 - 2022
Forecast period 2023 - 2031
Segments Covered By Type
  • Idiopathic
  • Diabetic
  • Post-Surgical
  • Others
By Drug Class Type
  • Prokinetic Agents
  • Antiemetic Agents
  • Botulinum Toxin Injection
By Distribution Channel
  • Hospital Pharmacies
  • Retail Pharmacies
  • Others
Regions and Countries Covered North America
  • US
  • Canada
  • Mexico
  • UK
  • Germany
  • France
  • Russia
  • Italy
  • Rest of Europe
  • China
  • India
  • Japan
  • Australia
  • Rest of Asia-Pacific
South and Central America
  • Brazil
  • Argentina
  • Rest of South and Central America
Middle East and Africa
  • South Africa
  • Saudi Arabia
  • UAE
  • Rest of Middle East and Africa
Market leaders and key company profiles
  • Bausch Health Companies Inc.(Salix Pharmaceuticals, Ltd.)
  • Johnson And Johnson Services, Inc.
  • Allergan Plc
  • Pfizer Inc.
  • ANI Pharmaceuticals, Inc.
  • Ipca Laboratories Ltd.
  • Cinrx Pharma, LLC (Cindome Pharma)
    • Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.

    Gastroparesis Market News and Recent Developments

    The Gastroparesis Market is evaluated by gathering qualitative and quantitative data post primary and secondary research, which includes important corporate publications, association data, and databases. The following is a list of developments in the market for gastroparesis and strategies:

    • The Food and Drug Administration (FDA) has accepted for review the New Drug Application (NDA) for tradipitant for the treatment of gastroparesis. (Source: Vanda Pharmaceuticals, Press Release/Newsletter, 2023)
    • The company treated the first participant with its potential best-in-class pan-GI prokinetic, naronapride, in Europe in a Phase IIb trial to treat gastroparesis. (Source: Renexxion Ireland, Press Release/Company Website/Newsletter, 2023)

    Gastroparesis Market Report Coverage and Deliverables

    The “Gastroparesis Market Size and Forecast (2021–2031)” report provides a detailed analysis of the market covering below areas:

    • Market size and forecast at global, regional, and country levels for all the key market segments covered under the scope
    • Market dynamics such as drivers, restraints, and key opportunities
    • Key future trends
    • Detailed PEST/Porter’s Five Forces and SWOT analysis
    • Global and regional market analysis covering key market trends, major players, regulations, and recent market developments
    • Industry landscape and competition analysis covering market concentration, heat map analysis, prominent players, and recent developments
    • Detailed company profiles
    Report Coverage
    Report Coverage

    Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends

    Segment Covered
    Segment Covered

    Gastroparesis Type , Drug Class Type , and Distribution Channel

    Regional Scope
    Regional Scope

    North America, Europe, Asia Pacific, Middle East & Africa, South & Central America

    Country Scope
    Country Scope

    Argentina, Australia, Brazil, Canada, China, France, Germany, India, Italy, Japan, Mexico, Saudi Arabia, South Africa, South Korea, Spain, United Arab Emirates, United Kingdom, United States

    The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.

    1. Data Collection and Secondary Research:

    As a market research and consulting firm operating from a decade, we have published many reports and advised several clients across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.

    Several associations trade associates, technical forums, institutes, societies and organizations are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in the last 3 years are scrutinized and analyzed to understand the current market trends.

    1. Primary Research:

    The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.

    For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/Sales Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.

    A typical research interview fulfils the following functions:

    • Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
    • Validates and strengthens in-house secondary research findings
    • Develops the analysis team’s expertise and market understanding

    Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:

    • Industry participants: VPs, business development managers, market intelligence managers and national sales managers
    • Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.

    Below is the breakup of our primary respondents by company, designation, and region:

    Research Methodology

    Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.

    1. Data Analysis:

    Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.

    • 3.1 Macro-Economic Factor Analysis:

    We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.

    • 3.2 Country Level Data:

    Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.

    • 3.3 Company Profile:

    The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.

    • 3.4 Developing Base Number:

    Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.

    1. Data Triangulation and Final Review:

    The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.

    We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.

    We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.

    Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

    Trends and growth analysis reports related to Gastroparesis Market